Home | Safety and effect of Itolizumab in extracorporeal circulation, phase I/II

The revisions let you track differences between multiple versions of a post.

To edit, publish or delete one of the revisions below, click on its saved date.

Published clinical_trials Safety and effect of Itolizumab in extracorporeal circulation, phase I/II has only one revision
RevisionStatus
Saved 22/08/2024 - 9:43am by Gladyscurrent revision (published)
Equipo de Trabajo del RPCEC | CENCEC - MINSAP
rpcec@cencec.sld.cu
Calle 5ta A Edificio CECMED-CENCEC 2do piso e/ 60 y 62 Miramar, Playa.CP 11300. La Habana, Cuba
Telef: (537) 216-4126 | (537) 216-4212 | (537) 216-4218.
Copyright © 2014-2022 All Rights Reserved.